Viking Therapeutics EPS - Earnings per Share 2014-2024 | VKTX
- Viking Therapeutics EPS for the quarter ending September 30, 2024 was $-0.22, a 4.35% decline year-over-year.
- Viking Therapeutics 2023 annual EPS was $-0.91, a 1.11% increase from 2022.
- Viking Therapeutics 2022 annual EPS was $-0.9, a 26.76% increase from 2021.
- Viking Therapeutics 2021 annual EPS was $-0.71, a 31.48% increase from 2020.
Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.